Allergan’s Juvederm Helps Fill Wrinkles In Firm’s Device Sales Growth
This article was originally published in The Gray Sheet
Executive Summary
Allergan's Juvederm dermal filler is helping to sustain growth of the firm's medical device business as the economic downturn puts a damper on its broader aesthetic treatment offerings
You may also be interested in...
Mentor Plans Expansion Of Prevelle Dermal Filler Line, Strategic Review
New additions to Mentor's fledgling Prevelle dermal filler portfolio in the U.S. will help grow its facial aesthetic product revenue in the next several years, the company said during a Nov. 5 second-quarter earnings call
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.